other material
confidence high
sentiment neutral
materiality 0.45
Solid Biosciences corrects FVC data error for patient five in IGNITE DMD trial; mean improvement +8.5%
Solid Biosciences Inc.
- Corrected 1.5-year FVC change for patient five: +22.5% (previously reported incorrectly).
- Mean percent predicted FVC improvement for patients 4-6: +8.5% (range +0.6% to +22.5%).
- Mean difference vs natural history decline of 7.5% was +16.0% over 1.5 years.
- All three patients treated with 2E14 vg/kg SGT-001 show stability or improvement.